GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (OSTO:SEDANA) » Definitions » Total Liabilities

Sedana Medical AB (OSTO:SEDANA) Total Liabilities : kr55.6 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sedana Medical AB Total Liabilities?

Sedana Medical AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr55.6 Mil.

Sedana Medical AB's quarterly Total Liabilities declined from Sep. 2023 (kr47.45 Mil) to Dec. 2023 (kr44.06 Mil) but then increased from Dec. 2023 (kr44.06 Mil) to Mar. 2024 (kr55.64 Mil).

Sedana Medical AB's annual Total Liabilities declined from Dec. 2021 (kr66.12 Mil) to Dec. 2022 (kr52.43 Mil) and declined from Dec. 2022 (kr52.43 Mil) to Dec. 2023 (kr44.06 Mil).


Sedana Medical AB Total Liabilities Historical Data

The historical data trend for Sedana Medical AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sedana Medical AB Total Liabilities Chart

Sedana Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 26.41 49.00 66.12 52.43 44.06

Sedana Medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.61 48.61 47.45 44.06 55.64

Sedana Medical AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sedana Medical AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=43.043+(1.012+0.0069999999999983
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=44.1

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=1014.057-969.995
=44.1

Sedana Medical AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=54.341+(1.288+0.0079999999999993
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=55.6

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=1044.179-988.542
=55.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sedana Medical AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sedana Medical AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Sedana Medical AB (OSTO:SEDANA) Business Description

Traded in Other Exchanges
Address
Vendevagen 89, Danderyd, SWE, SE-182 32
Sedana Medical AB is a Sweden-based medical technology company. It's Anaesthetic Conserving Device (AnaConDa) is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as isoflurane or sevoflurane to invasively ventilated patients. AnaConDa is a small device that is inserted in the breathing circuit between the ET-Tube and the Y-piece. The product range of the group is AnaConDa, AnaConDa-S, AnaConDa syringe, FlurAbsorb-S, FlurAbsorb accessory kit, Nafion line, and others. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.

Sedana Medical AB (OSTO:SEDANA) Headlines

No Headlines